Increased Metformin Clearance in Overweight and Obese Adolescents: A Pharmacokinetic Substudy of a Randomized Controlled Trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-2019
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Increased Metformin Clearance in Overweight and Obese Adolescents: A Pharmacokinetic Substudy of a Randomized Controlled Trial ; volume:20 ; number:4 ; day:10 ; month:5 ; year:2018 ; pages:365-374 ; date:8.2018
Pediatric drugs ; 20, Heft 4 (10.5.2018), 365-374, 8.2018
- Urheber
-
Rongen, Anne van
- Beteiligte Personen und Organisationen
-
Aa, Marloes P. van der
Matic, Maja
Schaik, Ron H. N. van
Deneer, Vera H. M.
Vorst, Marja M. van der
Knibbe, Catherijne A. J.
SpringerLink (Online service)
- DOI
-
10.1007/s40272-018-0293-1
- URN
-
urn:nbn:de:101:1-2018091120220588076395
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rongen, Anne van
- Aa, Marloes P. van der
- Matic, Maja
- Schaik, Ron H. N. van
- Deneer, Vera H. M.
- Vorst, Marja M. van der
- Knibbe, Catherijne A. J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Bidirectional pharmacokinetic drug interactions between olaparib and metformin
The OCT2/MATE1 Interaction Between Trifluridine, Metformin and Cimetidine: A Crossover Pharmacokinetic Study
Renal safety of zoledronic acid with thalidomide in patients with myeloma: a pharmacokinetic and safety sub-study
Metformin increases fasting glucose clearance and endogenous glucose production in non-diabetic individuals
Metformin may adversely affect orthostatic blood pressure recovery in patients with type 2 diabetes: substudy from the placebo-controlled Copenhagen Insulin and Metformin Therapy (CIMT) trial
Liraglutide and the management of overweight and obesity in people with severe mental illness: qualitative sub-study
Enhanced renal clearance and impact on vancomycin pharmacokinetic parameters in patients with hemorrhagic stroke
Pharmacokinetic–Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance
An in vivo pharmacokinetic study of metformin microparticles as an oral sustained release formulation in rabbits
Comparison of Beinaglutide Versus Metformin for Weight Loss in Overweight and Obese Non-diabetic Patients
Correction to: Pharmacokinetic–Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance
An epigenetic aging analysis of randomized metformin and weight loss interventions in overweight postmenopausal breast cancer survivors
Bidirectional pharmacokinetic drug interactions between olaparib and metformin
The OCT2/MATE1 Interaction Between Trifluridine, Metformin and Cimetidine: A Crossover Pharmacokinetic Study
Renal safety of zoledronic acid with thalidomide in patients with myeloma: a pharmacokinetic and safety sub-study
Metformin increases fasting glucose clearance and endogenous glucose production in non-diabetic individuals
Metformin may adversely affect orthostatic blood pressure recovery in patients with type 2 diabetes: substudy from the placebo-controlled Copenhagen Insulin and Metformin Therapy (CIMT) trial
Liraglutide and the management of overweight and obesity in people with severe mental illness: qualitative sub-study
Enhanced renal clearance and impact on vancomycin pharmacokinetic parameters in patients with hemorrhagic stroke
Pharmacokinetic–Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance
An in vivo pharmacokinetic study of metformin microparticles as an oral sustained release formulation in rabbits
Comparison of Beinaglutide Versus Metformin for Weight Loss in Overweight and Obese Non-diabetic Patients
Correction to: Pharmacokinetic–Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance
An epigenetic aging analysis of randomized metformin and weight loss interventions in overweight postmenopausal breast cancer survivors
Bidirectional pharmacokinetic drug interactions between olaparib and metformin
The OCT2/MATE1 Interaction Between Trifluridine, Metformin and Cimetidine: A Crossover Pharmacokinetic Study
Renal safety of zoledronic acid with thalidomide in patients with myeloma: a pharmacokinetic and safety sub-study
Metformin increases fasting glucose clearance and endogenous glucose production in non-diabetic individuals
Metformin may adversely affect orthostatic blood pressure recovery in patients with type 2 diabetes: substudy from the placebo-controlled Copenhagen Insulin and Metformin Therapy (CIMT) trial
Liraglutide and the management of overweight and obesity in people with severe mental illness: qualitative sub-study
Enhanced renal clearance and impact on vancomycin pharmacokinetic parameters in patients with hemorrhagic stroke
Pharmacokinetic–Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance
An in vivo pharmacokinetic study of metformin microparticles as an oral sustained release formulation in rabbits
Comparison of Beinaglutide Versus Metformin for Weight Loss in Overweight and Obese Non-diabetic Patients
Correction to: Pharmacokinetic–Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance